Rising rates of alcohol-associated liver disease will lead to major increases in costs to the healthcare system and society over the next two decades, according to a new study published in the American Journal of Gastroenterology (2024;119[2]:270-277).
The annual cost of ALD is projected to more than double between 2022 and 2040, increasing from $31 billion to $66 billion. Overall, ALD is expected to cost the United States approximately $880 billion—$355 billion in direct